Cite
APA Citation
Kuo, S., Ye, W., Duong, J., & Herman, W. H. (2018). are the favorable cardiovascular outcomes of empagliflozin treatment explained by its effects on multiple cardiometabolic risk factors? A simulation of the results of the EMPA-REG OUTCOME trial. Diabetes research and clinical practice, 141, 181–189. http://access.bl.uk/ark:/81055/vdc_100066135655.0x000029